In a regulatory filing, Centessa (CNTA) Pharmaceuticals CEO Saurabh Saha disclosed the sale of 55,000 ordinary shares of the company on December 20 at a price of $17.4374 per share.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNTA: